{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:31:57Z","timestamp":1777307517178,"version":"3.51.4"},"reference-count":66,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2023-I2M-2-009"],"award-info":[{"award-number":["2023-I2M-2-009"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773750"],"award-info":[{"award-number":["81773750"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes &amp; Diseases"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.gendis.2025.101974","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T17:32:22Z","timestamp":1765474342000},"page":"101974","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of PLXNC1 as a novel biomarker for consensus molecular subtype 4 in colorectal cancer"],"prefix":"10.1016","volume":"13","author":[{"given":"Weiqi","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingxuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiegang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqiang","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silin","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zifan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3827-5961","authenticated-orcid":false,"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gendis.2025.101974_bib1","series-title":"World Cancer Report: Cancer Research for Cancer Prevention","author":"Wild","year":"2021"},{"issue":"2","key":"10.1016\/j.gendis.2025.101974_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.gendis.2025.101974_bib3","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.14694\/EdBook_AM.2015.35.e149","article-title":"Overcoming resistance to anti-EGFR therapy in colorectal cancer","author":"Dienstmann","year":"2015","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"2","key":"10.1016\/j.gendis.2025.101974_bib4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrc.2016.126","article-title":"Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer","volume":"17","author":"Dienstmann","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"10.1016\/j.gendis.2025.101974_bib5","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.gendis.2025.101974_bib6","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/ijc.28387","article-title":"Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition","volume":"134","author":"Roepman","year":"2014","journal-title":"Int J Cancer"},{"issue":"16","key":"10.1016\/j.gendis.2025.101974_bib7","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1158\/1078-0432.CCR-15-2879","article-title":"Immune and stromal classification of colorectal cancer is associated with molecular subtypes and relevant for precision immunotherapy","volume":"22","author":"Becht","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.gendis.2025.101974_bib8","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0896-6273(95)90266-X","article-title":"Plexin: a novel neuronal cell surface molecule that mediates cell adhesion via a homophilic binding mechanism in the presence of calcium ions","volume":"14","author":"Ohta","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.gendis.2025.101974_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.662707","article-title":"PLXNC1: a novel potential immune-related target for stomach adenocarcinoma","volume":"9","author":"Ni","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.gendis.2025.101974_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fonc.2020.00033","article-title":"PLXNC1 enhances carcinogenesis through transcriptional activation of IL6ST in gastric cancer","volume":"10","author":"Chen","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.gendis.2025.101974_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4040787","article-title":"Plexin C1 marks liver cancer cells with epithelial phenotype and is overexpressed in hepatocellular carcinoma","volume":"2018","author":"Odabas","year":"2018","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"89","key":"10.1016\/j.gendis.2025.101974_bib12","doi-asserted-by":"crossref","first-page":"56280","DOI":"10.1039\/C7RA08518D","article-title":"The role of semaphorin 7A and its receptor plexin C1 in the migration of NSCLC cells","volume":"7","author":"Zhang","year":"2017","journal-title":"RSC Adv"},{"issue":"4\u20136","key":"10.1016\/j.gendis.2025.101974_bib13","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12672-019-00366-1","article-title":"miR-4500 regulates PLXNC1 and inhibits papillary thyroid cancer progression","volume":"10","author":"Li","year":"2019","journal-title":"Horm Cancer"},{"issue":"1","key":"10.1016\/j.gendis.2025.101974_bib14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1182\/bloodadvances.2021004878","article-title":"An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia","volume":"6","author":"Ragaini","year":"2022","journal-title":"Blood Adv"},{"issue":"9","key":"10.1016\/j.gendis.2025.101974_bib15","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1002\/eji.201343968","article-title":"The plexin C1 receptor promotes acute inflammation","volume":"44","author":"K\u00f6nig","year":"2014","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101974_bib16","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1186\/s13018-023-04207-4","article-title":"PLXNC1 interference alleviates the inflammatory injury, apoptosis and extracellular matrix degradation of IL-1\u03b2-exposed chondrocytes via suppressing GRP78 expression","volume":"18","author":"Meng","year":"2023","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"10.1016\/j.gendis.2025.101974_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1476-5586(04)80047-2","article-title":"ONCOMINE: a cancer microarray database and integrated data-mining platform","volume":"6","author":"Rhodes","year":"2004","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.gendis.2025.101974_bib18","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.1038\/s41467-019-13528-0","article-title":"Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers","volume":"10","author":"Chen","year":"2019","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.gendis.2025.101974_bib19","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN a portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"issue":"10","key":"10.1016\/j.gendis.2025.101974_bib20","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The cancer genome Atlas pan-cancer analysis project","volume":"45","author":"Weinstein","year":"2013","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.gendis.2025.101974_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001453","article-title":"Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value","volume":"10","author":"Marisa","year":"2013","journal-title":"PLoS Med"},{"issue":"10","key":"10.1016\/j.gendis.2025.101974_bib22","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1089\/omi.2012.0039","article-title":"A seven-gene signature aggregates a subgroup of stage II colon cancers with stage III","volume":"16","author":"Laibe","year":"2012","journal-title":"OMICS"},{"issue":"3","key":"10.1016\/j.gendis.2025.101974_bib23","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1053\/j.gastro.2009.11.005","article-title":"Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer","volume":"138","author":"Smith","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gendis.2025.101974_bib24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1755-8794-5-66","article-title":"Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines","volume":"5","author":"Schlicker","year":"2012","journal-title":"BMC Med Genom"},{"key":"10.1016\/j.gendis.2025.101974_bib25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cellsig.2017.09.018","article-title":"Logarithmic expansion of LGR5+ cells in human colorectal cancer","volume":"42","author":"Martin","year":"2018","journal-title":"Cell Signal"},{"issue":"17","key":"10.1016\/j.gendis.2025.101974_bib26","doi-asserted-by":"crossref","first-page":"7131","DOI":"10.1073\/pnas.0902232106","article-title":"Association of survival and disease progression with chromosomal instability: a genomic exploration of colorectal cancer","volume":"106","author":"Sheffer","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Database issue","key":"10.1016\/j.gendis.2025.101974_bib27","first-page":"D991","article-title":"NCBI GEO: archive for functional genomics data sets: update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"43","key":"10.1016\/j.gendis.2025.101974_bib28","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gendis.2025.101974_bib29","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.gendis.2025.101974_bib30","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"issue":"1","key":"10.1016\/j.gendis.2025.101974_bib31","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","article-title":"Comprehensive analyses of tumor immunity: implications for cancer immunotherapy","volume":"17","author":"Li","year":"2016","journal-title":"Genome Biol"},{"issue":"4","key":"10.1016\/j.gendis.2025.101974_bib32","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.gendis.2025.101974_bib33","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.gendis.2025.101974_bib34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.celrep.2018.03.076","article-title":"Genomic and molecular landscape of DNA damage repair deficiency across the cancer genome atlas","volume":"23","author":"Knijnenburg","year":"2018","journal-title":"Cell Rep"},{"issue":"6","key":"10.1016\/j.gendis.2025.101974_bib35","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41588-020-0636-z","article-title":"Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer","volume":"52","author":"Lee","year":"2020","journal-title":"Nat Genet"},{"issue":"D1","key":"10.1016\/j.gendis.2025.101974_bib36","doi-asserted-by":"crossref","first-page":"D870","DOI":"10.1093\/nar\/gkac947","article-title":"CellMarker 2.0: an updated database of manually curated cell markers in human\/mouse and web tools based on scRNA-seq data","volume":"51","author":"Hu","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.gendis.2025.101974_bib37","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.gendis.2025.101974_bib38","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s10585-005-3585-0","article-title":"Mouse colon carcinoma cells established for high incidence of experimental hepatic metastasis exhibit accelerated and anchorage-independent growth","volume":"22","author":"Morimoto-Tomita","year":"2005","journal-title":"Clin Exp Metastasis"},{"issue":"8","key":"10.1016\/j.gendis.2025.101974_bib39","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/cdd.2014.45","article-title":"Tumor cell-activated CARD9 signaling contributes to metastasis-associated macrophage polarization","volume":"21","author":"Yang","year":"2014","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.gendis.2025.101974_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.594098","article-title":"Indoleamine 2, 3-dioxygenase 1 and CD8 expression profiling revealed an immunological subtype of colon cancer with a poor prognosis","volume":"10","author":"Zhang","year":"2020","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101974_bib41","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13073-020-00783-w","article-title":"The murine microenvironment cell population counter method to estimate abundance of tissue-infiltrating immune and stromal cell populations in murine samples using gene expression","volume":"12","author":"Petitprez","year":"2020","journal-title":"Genome Med"},{"issue":"1","key":"10.1016\/j.gendis.2025.101974_bib42","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-019-0638-6","article-title":"Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data","volume":"11","author":"Finotello","year":"2019","journal-title":"Genome Med"},{"key":"10.1016\/j.gendis.2025.101974_bib43","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.26476","article-title":"Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data","volume":"6","author":"Racle","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.gendis.2025.101974_bib44","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejca.2019.09.008","article-title":"The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications","volume":"123","author":"Soldevilla","year":"2019","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.gendis.2025.101974_bib45","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1053\/j.gastro.2019.09.045","article-title":"Therapeutic targeting of the colorectal tumor stroma","volume":"158","author":"Fridman","year":"2020","journal-title":"Gastroenterology"},{"issue":"13","key":"10.1016\/j.gendis.2025.101974_bib46","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1158\/1078-0432.CCR-14-2926","article-title":"Orchestration and prognostic significance of immune checkpoints in the microenvironment of primary and metastatic renal cell cancer","volume":"21","author":"Giraldo","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.gendis.2025.101974_bib47","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1172\/JCI127046","article-title":"Immune overdrive signature in colorectal tumor subset predicts poor clinical outcome","volume":"129","author":"Fakih","year":"2019","journal-title":"J Clin Investig"},{"issue":"5","key":"10.1016\/j.gendis.2025.101974_bib48","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.gendis.2025.101974_bib49","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1080\/21645515.2017.1327107","article-title":"Transforming growth factor-\u03b2: a therapeutic target for cancer","volume":"13","author":"Haque","year":"2017","journal-title":"Hum Vaccin Immunother"},{"issue":"6024","key":"10.1016\/j.gendis.2025.101974_bib50","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"issue":"6280","key":"10.1016\/j.gendis.2025.101974_bib51","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1126\/science.aaf1490","article-title":"Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade","volume":"351","author":"McGranahan","year":"2016","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.gendis.2025.101974_bib52","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12943-019-0976-4","article-title":"Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis","volume":"18","author":"Wei","year":"2019","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.gendis.2025.101974_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.2017.136","article-title":"Hallmarks of response to immune checkpoint blockade","volume":"117","author":"Cogdill","year":"2017","journal-title":"Br J Cancer"},{"issue":"8","key":"10.1016\/j.gendis.2025.101974_bib54","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1172\/JCI120775","article-title":"Emerging strategies for combination checkpoint modulators in cancer immunotherapy","volume":"128","author":"Popovic","year":"2018","journal-title":"J Clin Investig"},{"issue":"3","key":"10.1016\/j.gendis.2025.101974_bib55","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028480","article-title":"Interferon \u03b3 and its important roles in promoting and inhibiting spontaneous and therapeutic cancer immunity","volume":"11","author":"Alspach","year":"2019","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"7407","key":"10.1016\/j.gendis.2025.101974_bib56","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature11252","article-title":"Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","year":"2012","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.gendis.2025.101974_bib57","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41418-017-0011-5","article-title":"Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models","volume":"25","author":"Linnekamp","year":"2018","journal-title":"Cell Death Differ"},{"issue":"1","key":"10.1016\/j.gendis.2025.101974_bib58","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13046-023-02600-9","article-title":"Subtype-specific kinase dependency regulates growth and metastasis of poor-prognosis mesenchymal colorectal cancer","volume":"42","author":"Buikhuisen","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.gendis.2025.101974_bib59","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1158\/1078-0432.CCR-20-2403","article-title":"Development and validation of a gene signature classifier for consensus molecular subtyping of colorectal carcinoma in a CLIA-certified setting","volume":"27","author":"Morris","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.gendis.2025.101974_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153379","article-title":"A modified protein marker panel to identify four consensus molecular subtypes in colorectal cancer using immunohistochemistry","volume":"220","author":"Li","year":"2021","journal-title":"Pathol Res Pract"},{"issue":"2","key":"10.1016\/j.gendis.2025.101974_bib61","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1158\/1078-0432.CCR-16-0680","article-title":"Practical and robust identification of molecular subtypes in colorectal cancer by immunohistochemistry","volume":"23","author":"Trinh","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.gendis.2025.101974_bib62","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/gutjnl-2019-319866","article-title":"Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning","volume":"70","author":"Sirinukunwattana","year":"2021","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.gendis.2025.101974_bib63","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","article-title":"Guidelines and definitions for research on epithelial-mesenchymal transition","volume":"21","author":"Yang","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"10.1016\/j.gendis.2025.101974_bib64","doi-asserted-by":"crossref","first-page":"745","DOI":"10.15252\/emmm.201606184","article-title":"TGF\u03b2 signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype","volume":"8","author":"Fessler","year":"2016","journal-title":"EMBO Mol Med"},{"issue":"4","key":"10.1016\/j.gendis.2025.101974_bib65","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrc3245","article-title":"The immune contexture in human tumours: impact on clinical outcome","volume":"12","author":"Fridman","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.gendis.2025.101974_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1160052","article-title":"Genomic landscape and expression profile of consensus molecular subtype four of colorectal cancer","volume":"14","author":"Lu","year":"2023","journal-title":"Front Immunol"}],"container-title":["Genes &amp; Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304225004635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304225004635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T15:32:39Z","timestamp":1777303959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304225004635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2352304225004635"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2025.101974","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of PLXNC1 as a novel biomarker for consensus molecular subtype 4 in colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2025.101974","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101974"}}